| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.66B | -3.8% |
| Cost of Revenue | $2.98B | -2.9% |
| Gross Profit | $1.68B | -5.2% |
| R&D Expense | $122.5M | -34.6% |
| SG&A Expense | $522.3M | +3.8% |
| Operating Income | $151.9M | -25.8% |
| Pre-tax Income | -$8.3M | — |
| Income Tax | -$3.9M | -115.7% |
| Net Income | -$12.7M |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $739.6M | -40.5% |
| Inventory | $1.14B | +17.9% |
| Current Assets | $2.83B | +2.8% |
| Total Assets | $10.81B | -4.4% |
| Current Liabilities | $1.59B | +18.8% |
| Long-term Debt | $3.63B | +7.9% |
| Total Liabilities | $6.04B | +9.9% |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $405.5M | +4.6% |
| Capital Expenditures | $101.7M | -26.1% |
| Investing Cash Flow | -$77.5M | +87.0% |
| Financing Cash Flow | -$187.2M | — |
| Free Cash Flow | $303.8M | +21.5% |
| -108.7% |
| EPS (Basic) | -$0.09 | -108.4% |
| EPS (Diluted) | -$0.09 | -108.4% |
| Stockholders' Equity |
| $5.66B |
| -2.6% |